TRASTUZUMAB DERUXTECAN 100MG POWDER FOR CONCENTRATE FOR SOLN FOR INFUSION

Official notice

Authority: Western Health and Social Care Trust (Central government)

Direct award

Sectors: Medical Devices & Pharma (33) Delivery: Northern Ireland (UKN)

Awarded value£428,352published award · exc. VAT

Awarded 23 Mar 2026no call for competition

Awarded to Alloga UK

What is being bought

Published requirement description

Supply of TRASTUZUMAB DERUXTECAN 100MG POWDER FOR CONCENTRATE FOR SOLN FOR INFUSION to meet clinical need in the Western Trust until 20/04/2029

The lotProcurement structure

single lot · no lot value published

Lot #1Awarded

Delivery: Northern Ireland

33600000 Pharmaceutical products

Procedure terms & legal framework

From the official record

Procedure method: Direct award
Legal basis: UKPGA · 2023/54 Procurement Act 2023
Notice status: Awarded without competition
Procurement threshold: Unspecified in notice
Regulatory regime: Standard
Commercial structure: Stand-alone contract (no framework)
Competition type: Direct award (no call for competition)
GPA / WTO covered: Yes (GPA)
Recurring procurement: Unspecified in notice
First published: 8 Apr 2026, 09:52 BST
Last source update: 22 Apr 2026, 09:25 BST
Authority reference: WT-PHARM-2026-02
FTS notice number: 2026/S 000-036404
Latest notice: Contract details notice (UK7)
Delivery area: Northern Ireland (UKN)
Official registry OCID: ocds-h6vhtk-067d8f Find a Tender

Why no open competition: Single Suppliers Intellectual Property Exclusive Rights
Published justification: Section 41 of the PA2023, permits a direct award in specific cases. Schedule 5 of the PA2023 sets out justifications for direct award - this particular supplier having intellectual property rights or other exclusive rights, only this supplier can supply the goods, services or works required, and
(b)there are no reasonable alternatives to those goods, services or works

Notice history

4 events · 3 releases on Find a Tender · since 8 Apr 2026

Transparency notice published
8 Apr 2026, 09:52 BST
UK5
Contract award notice published
8 Apr 2026, 10:00 BST
UK6
Contract signature expected
21 Apr 2026, 23:59 BST
scheduled
Contract details notice published
22 Apr 2026, 09:25 BST
UK7

Commercial outcome & contract awards

Published awards, contracts and bid statistics, not a forecast

Awards 1

Awarded value £428,3521 award exc. VAT

Contracts signed 1latest 23 Mar 2026

Awarded to	Value	Date	Status
Alloga UK21 Apr 2026 – 20 Apr 2029	£428,352	23 Mar 2026	Awarded

Contracts

TRASTUZUMAB DERUXTECAN 100MG POWDER FOR CONCENTRATE FOR SOLN FOR INFUSION · Alloga UK
Signed
23 Mar 2026
Value
£428,352
Period
21 Apr 2026 – 20 Apr 2029
Status
active
No agreed KPIs: Relevant thresholds not met

Contracting authority & participating public bodies

Western Health & Social Care Trust

Contracting authorityPublic authority - central governmentNorthern Irish devolved regulations apply GB-PPON: PTVW-2397-PWCT Altnagelvin Area Hospital, Glenshane Road, Londonderry, Northern Ireland, BT47 6SBContact name, email, phone

Bidders & participating suppliers

1 commercial party on the notice

ALLOGA UK LIMITEDAwarded supplierGB-COH: 03169255GB-PPON: PBTH-6754-GVPN Amber Park, Alfreton, East Midlands, DE55 2FHContact email

Official documents & specifications (3)

Official links; attachments are not copied

Notices published for this procedure

Contract details notice contractContract details noticeUK7Contract details notice on Find a Tender22 Apr 2026, 09:25 BST
Contract award notice awardContract award noticeUK6Contract award notice on Find a Tender8 Apr 2026, 10:00 BST
Transparency notice awardTransparency noticeUK5Transparency notice on Find a Tender8 Apr 2026, 09:52 BST